About this trial

Test the feasibility of using electrocorticography (ECoG) signals to control complex devices for motor and speech control in adults severely affected by neurological disorders.

Eligibility criteria

Qualifiers

Age > 21

Limited ability to use upper limbs, based on neurological examination, due to stroke, amyotrophic lateral sclerosis (ALS), multiple sclerosis, cervical spinal cord injury, brainstem stroke, muscular dystrophy, myopathy or severe neuropathy.

Disability, defined by a 4 or greater score on the Modified Rankin Scale, must be severe enough to cause loss of independence and inability to perform activities of daily living.

If stroke or spinal cord injury, at least 1 year has passed since onset of symptoms

Disqualifiers

Pregnancy or breastfeeding

Inability to understand and/or read English

Inability to give consent

Dementia, based on history, physical exam, and MMSE

Trial design

Treatments tested in this trial

  • PMT/Blackrock Combination Device

Treatment groups

3 Participants
are divided into 1 treatment group

Locations

1
University of California San Francisco94158, San FranciscoCalifornia, United States

Sponsors and collaborators

Karunesh Ganguly

Lead sponsor

University of California, San Francisco

Sponsor institution

National Institute on Deafness and Other Communication Disorders (NIDCD)

Collaborator